SCHEMBL14380486

SCHEMBL14380486

CSc1cnc(OCCOc2ncnc(NS(=O)(=O)NCc3ccccn3)c2-c2ccc(Cl)cc2)nc1

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EDNRA P25101 18/20 0.76
▸ EDNRB P24530 17/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14380474 0.92 EDNRB (0.76) EDNRAEDNRB
SCHEMBL14380488 0.89 EDNRA (0.65) EDNRAEDNRB
SCHEMBL14380482 0.89 EDNRA (0.80) EDNRAEDNRB
SCHEMBL14380492 0.87 EDNRA (0.78) EDNRAEDNRB
SCHEMBL14380770 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL14380489 0.86 EDNRA (0.75) EDNRAEDNRB
SCHEMBL14380515 0.85 EDNRA (0.76) EDNRAEDNRB
SCHEMBL14380530 0.85 EDNRA (1.00) EDNRAEDNRB
SCHEMBL14380516 0.85 EDNRA (0.75) EDNRAEDNRB
SCHEMBL14380496 0.85 EDNRA (0.77) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285549-B2 Sulfamides and their use as endothelin receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2007-10-23 — — US disclosed
US-7285549-B2 Sulfamides and their use as endothelin receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2007-10-23 — — US disclosed
Send feedback